Detalles de la búsqueda
1.
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting.
Support Care Cancer
; 32(1): 36, 2023 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38105286
2.
The degree of satisfaction and level of learning in male and female surgical residents: a nationwide questionnaire survey of graduating residents in Japan.
Surg Today
; 53(11): 1275-1285, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37162584
3.
High platelet-to-lymphocyte ratios in triple-negative breast cancer associates with immunosuppressive status of TILs.
Breast Cancer Res
; 24(1): 67, 2022 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36217150
4.
Involvement of kallikrein-PAR2-proinflammatory pathway in severe trastuzumab-induced cardiotoxicity.
Cancer Sci
; 113(10): 3449-3462, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35879248
5.
Brca1L63X /+ rat is a novel model of human BRCA1 deficiency displaying susceptibility to radiation-induced mammary cancer.
Cancer Sci
; 113(10): 3362-3375, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35851737
6.
Absolute lymphocyte count decreases with disease progression and is a potential prognostic marker for metastatic breast cancer.
Breast Cancer Res Treat
; 196(2): 291-298, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36156756
7.
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients.
BMC Cancer
; 22(1): 242, 2022 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35248011
8.
Depressive and anxiety symptoms among Japanese cancer survivors: Japan cancer survivorship research project.
BMC Cancer
; 22(1): 134, 2022 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35109805
9.
Short somatic alterations at the site of copy number variation in breast cancer.
Cancer Sci
; 112(1): 444-453, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32860329
10.
Predictors of resignation and sick leave after cancer diagnosis among Japanese breast cancer survivors: a cross-sectional study.
BMC Public Health
; 21(1): 138, 2021 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33446165
11.
Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer.
Cancer Sci
; 111(9): 3313-3326, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32619077
12.
Microsatellite instability and mismatch repair protein expressions in lymphocyte-predominant breast cancer.
Cancer Sci
; 111(7): 2647-2654, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32449246
13.
High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer.
Breast Cancer Res Treat
; 183(1): 41-48, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32572714
14.
Is there disparity between regions and facilities in surgical resident training in Japan? Insights from a national survey.
Surg Today
; 50(12): 1585-1593, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32488479
15.
Are graduating residents sufficiently competent? Results of a national gap analysis survey of program directors and graduating residents in Japan.
Surg Today
; 50(9): 995-1001, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32125504
16.
A snapshot of surgical resident training in Japan: results of a national-level needs assessment survey.
Surg Today
; 49(10): 870-876, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31102022
17.
Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study.
J Transl Med
; 16(1): 287, 2018 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30342534
18.
Randomized phase II study of nab-paclitaxel as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.
Cancer Sci
; 108(5): 987-994, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28256066
19.
Efficacy and safety of low-dose capecitabine plus docetaxel versus single-agent docetaxel in patients with anthracycline-pretreated HER2-negative metastatic breast cancer: results from the randomized phase III JO21095 trial.
Breast Cancer Res Treat
; 161(3): 473-482, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28005247
20.
Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
Breast Cancer Res Treat
; 162(3): 501-510, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28181129